Skip to content
JMG Blog logo
  • Home
  • Journal

About:hqqu

Profile
Huiqi Qu’s research interest is the genetics and functional genomics of human complex diseases (e.g. tuberculosis, obesity, and diabetes). He is working on the genetics and functional genomics of tuberculosis and diabetes. By integrating proteomics, genomics, and GWAS study, they are trying to clarify the molecular mechanisms of tuberculosis susceptibility, and develop genetic markers for diabetes risk prediction.

Posts by hqqu :

  • From gestalt to gene: early predictive dysmorphic features of PMM2-CDG, Posted on November 21, 2018 by hqqu in Uncategorized
  • Cancer immunotherapy: challenges and clinical applications, Posted on November 21, 2018 by hqqu in Uncategorized
  • Practice evaluation of biobank ethics and governance: current needs and future perspectives, Posted on November 21, 2018 by hqqu in Uncategorized
  • Novel homozygous CFAP69 mutations in humans and mice cause severe asthenoteratospermia with multiple morphological abnormalities of the sperm flagella, Posted on November 10, 2018 by hqqu in Uncategorized
  • Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy, Posted on November 10, 2018 by hqqu in Uncategorized
  • Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations, Posted on November 10, 2018 by hqqu in Uncategorized
  • Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options, Posted on October 23, 2018 by hqqu in Uncategorized
  • Medical consequences of pathogenic CNVs in adults: Analysis of the UK Biobank, Posted on October 21, 2018 by hqqu in Uncategorized
  • De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy, Posted on October 15, 2018 by hqqu in Uncategorized
  • Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations, Posted on October 5, 2018 by hqqu in Uncategorized
  • «Previous page
  • 48
  • 49
  • 50
  • 51
  • 52
  • »Next page
  • 98

BMJ Careers

BMJ Blogs

Comment and Opinion | Open Debate

The views and opinions expressed on this site are solely those of the original authors. They do not necessarily represent the views of BMJ and should not be used to replace medical advice. Please see our full website terms and conditions.

All BMJ blog posts are posted under a CC-BY-NC licence

BMJ Journals

© BMJ Publishing Group Limited 2025. All rights reserved.